
In a poster at the 2022 SOC scientific symposium, Andrew Alexis, MD, MPH, examined the efficacy of one AD drug against race and ethnicity.

In a poster at the 2022 SOC scientific symposium, Andrew Alexis, MD, MPH, examined the efficacy of one AD drug against race and ethnicity.

In a presentation at the current AAD annual meeting, experts discussed differential diagnoses and clinical presentations in birthmarks and hamartomas.

Mariam Totonchy, MD, and Chrysalyne D. Schmults, MD, MSCE, discuss best practices when caring for high-risk cSCC patients, including surgical vs nonsurgical options, imaging, and follow-up protocol.

Today, the 18th Annual Skin of Color Scientific Symposium begins, showcasing new research in the field, key insights, and the evolution in skin of color dermatology.

The 3rd Annual San Diego Dermatology Symposium (SDDS) was held in-person for the first time on March 11 to 13, 2022, at the Hilton San Diego Bayfront, in California.

This weekend, March 11-13, 2022, the San Diego Dermatology Symposium (SDDS) will be educating physicians in person. Everything from traditional topics like atopic dermatitis to rare disease such as Stevens-Johnson syndrome will be covered.

Click here to answer this week's poll.

Poster presented at Maui Derm for Dermatologists 2022 reveals prognostic value of 2 independently validated algorithms.

Suneel Chilukuri, MD, discusses lower eyelid rejuvenation, including avoiding complications, in his presentation at the Maui Derm for Dermatologists meeting.

Suneel Chilukuri, MD, discusses new innovations in dermatology, including hyperpigmentation, in his presentation at the Maui Derm for Dermatologists meeting.

Robert S. Kirsner, MD, PhD, discusses new and tried-and-true wound healing methods in his presentation at the Maui Derm for Dermatologists meeting.

Improve patient outcomes in wound healing with the best practices of time-honored and cutting-edge approaches.

A poster presentation from Follica at the 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm for Dermatology meeting found that 56% of survey responders did not seek treatment for their hair loss, and that 19% of respondents who attempted treatment quit because of lack of efficacy or cost.

Linda Stein Gold, MD, discusses psoriasis in 2022, in her presentation at the current Maui Derm for Dermatologists meeting.

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.

New and exciting topical and oral therapies for psoriasis have changed the way dermatologists treat and manage their psoriasis patients.

Hyperpigmentation requires dermatologists to take a multimodal approach and be familiar with a menu of treatments, according to a presentation given at Maui Derm for Dermatologists 2022, held January 24 to 28, 2022 in Maui Hawaii, and virtual.

Patients suffering from a wide range of dermatologic diseases can benefit from the new and exciting therapies and treatment modalities that have recently become available.

Vial’s newly launched contract research organization (CRO) addressed ways to surmount some of the biggest obstacles blocking increased speed and quality of clinical trials with an advisory board meeting at Maui Derm for Dermatologists 2022.

Melanoma in Black patients presents unique challenges for dermatologists due to clinical diagnostic differences, provider bias, and a lack of patient awareness, according to a presentation given at Maui Derm 2022.

Neal Bhatia, MD, highlights the most exciting new drugs and therapies in atopic dermatitis and psoriasis in his presentation at the current Maui Derm for Dermatologists meeting.

Patients suffering from several dermatologic diseases and conditions including acne, rosacea, and pruritus can largely benefit from the new and exciting therapies and treatment modalities that have recently become available.

Maui Derm begins today in Maui, Hawaii, offering a multitude of presentations and workshops for the dermatology community.

Vial announced an advisory board to discuss dermatology CROs at the 2022 Winter Clinical Dermatology Conference.

The FDA approved the topical JAK1/JAK2 inhibitor ruxolitinib for the treatment of mild to moderate atopic dermatitis in September 2021.

Treating these patients can be a challenge, but it can also be ‘as easy as pie’ if you follow these tips.

One of the key differences between diagnosing AD in patients with skin of color compared to White skin is erythema.

AAD vice president challenges dermatologists to advocate for their patients and themselves.

Targeting skin care regimens to the individual patient is most likely to yield compliance to a recommended routine.

Resident billing can have huge financial implications on academic institutions. A poster from the Icahn School of Medicine at Mount Sinai aimed to assess new medical coding lectures and a modified note template at Winter Clinical Dermatology Conference.